Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination.

Yamada M, Kamberos N, Grose C.

J Pediatr. 2013 Nov;163(5):1511-3. doi: 10.1016/j.jpeds.2013.06.043. Epub 2013 Aug 6.

2.

Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.

Hayashida K, Ozaki T, Nishimura N, Gotoh K, Funahashi K, Nakane K, Gomi Y, Manabe S, Ishikawa T, Yamanishi K.

J Immunol Methods. 2015 Nov;426:50-5. doi: 10.1016/j.jim.2015.07.011. Epub 2015 Jul 29.

PMID:
26232696
3.

Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.

Terada K, Niizuma T, Yagi Y, Miyashima H, Kataoka N, Sadahiro T.

J Med Virol. 2000 Sep;62(1):46-51.

PMID:
10935988
4.

Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.

Wiese-Posselt M, Siedler A, Mankertz A, Sauerbrei A, Hengel H, Wichmann O, Poethko-Müller C.

BMC Infect Dis. 2017 May 19;17(1):356. doi: 10.1186/s12879-017-2461-2.

5.

Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.

Breuer J, Schmid DS, Gershon AA.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S147-51. doi: 10.1086/529448. Review.

PMID:
18419389
6.

Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.

Choi UY, Huh DH, Kim JH, Kang JH.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2560-2564. doi: 10.1080/21645515.2016.1190056. Epub 2016 Aug 2.

7.

The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.

Hammond O, Wang Y, Green T, Antonello J, Kuhn R, Motley C, Stump P, Rich B, Chirmule N, Marchese RD.

J Med Virol. 2006 Dec;78(12):1679-87.

PMID:
17063506
8.

Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.

Kopylov U, Levin A, Mendelson E, Dovrat S, Book M, Eliakim R, Ben-Horin S.

Aliment Pharmacol Ther. 2012 Jul;36(2):145-50. doi: 10.1111/j.1365-2036.2012.05150.x. Epub 2012 May 22. Erratum in: Aliment Pharmacol Ther. 2018 Jan;47(1):156.

9.

Seroprevalence of varicella-zoster virus in Polish population.

Siennicka J, Trzcińska A, Rosińska M, Litwińska B.

Przegl Epidemiol. 2009;63(4):495-9.

10.

Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.

Lafer MM, de Moraes-Pinto MI, Weckx LY.

Rev Inst Med Trop Sao Paulo. 2005 May-Jun;47(3):139-42. Epub 2005 Jul 12.

11.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
12.

Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.

Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.

Pediatr Infect Dis J. 2007 Jul;26(7):572-6.

PMID:
17596796
13.

Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I; Study Group for Varivax.

Pediatr Infect Dis J. 2004 Feb;23(2):132-7.

PMID:
14872179
14.

Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.

Saiman L, LaRussa P, Steinberg SP, Zhou J, Baron K, Whittier S, Della-Latta P, Gershon AA.

Infect Control Hosp Epidemiol. 2001 May;22(5):279-83.

PMID:
11428437
15.

Varicella immunity in vaccinated healthcare workers.

Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS.

J Clin Virol. 2013 Jun;57(2):109-14. doi: 10.1016/j.jcv.2013.01.015. Epub 2013 Feb 20.

PMID:
23434396
16.

Postpartum varicella vaccination: is the vaccine virus excreted in breast milk?

Bohlke K, Galil K, Jackson LA, Schmid DS, Starkovich P, Loparev VN, Seward JF.

Obstet Gynecol. 2003 Nov;102(5 Pt 1):970-7.

PMID:
14672472
17.
18.

Laboratory diagnosis and characteristics of breakthrough varicella in children.

Weinmann S, Chun C, Mullooly JP, Riedlinger K, Houston H, Loparev VN, Schmid DS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S132-8. doi: 10.1086/522148.

PMID:
18419386
19.

Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.

Prelog M, Schönlaub J, Jeller V, Almanzar G, Höfner K, Gruber S, Eiwegger T, Würzner R.

Vaccine. 2013 May 7;31(20):2420-6. doi: 10.1016/j.vaccine.2013.03.058. Epub 2013 Apr 10.

PMID:
23583889
20.

[Summary of the multidisciplinary guideline 'Varicella'].

Rothbarth PH, Hartwig NG, Opstelten W.

Ned Tijdschr Geneeskd. 2011;155(51):A3511. Review. Dutch.

PMID:
22200141

Supplemental Content

Support Center